Receive our newsletter – data, insights and analysis delivered to you
  1. Surveys
February 26, 2021updated 01 Mar 2021 5:56am

Clinical trials delay emerge as main concern amid COVID-19: Survey

The clinical trials delays have emerged as the main concern for the pharmaceutical and healthcare industry after the ongoing coronavirus pandemic disrupted more than 1,200 clinical trials across the world.

The clinical trials delays have emerged as the main concern for the pharmaceutical and healthcare industry after the ongoing coronavirus pandemic disrupted more than 1,200 clinical trials across the world.

GlobalData conducted a survey among pharmaceutical companies to identify their main concerns related to clinical trials in 2020.

Clinical trials delay emerge as main concern amid COVID-19Primary Clinical Trial Concerns Related to the Covid-19 Outbreak

The survey found that 30% of the respondents highlighted that the inability or delay to initiate clinical trials was the highest clinical trial-related concern.

Impact on clinical trial participants (26%) and safety of the patients recruited in trials (24%) were the second and third biggest concerns, respectively.

Around 11% of the respondents highlighted that negative impact on planned statistical goals submitted to agencies was the main concern, while another 7% opined loss of investment as the main concern.

Another 2% of the companies opined that they had other concerns related to clinical trials amid COVID-19.

The analysis is based on responses received for the Coronavirus Survey – COVID-19 and Decentralised Clinical Trials conducted by GlobalData between 04 June and 22 June 2020.

Related Companies

NEWSLETTER Sign up Tick the boxes of the newsletters you would like to receive. A weekly roundup of the latest news and analysis, sent every Friday. The pharmaceutical industry's most comprehensive news and information delivered every month.
I consent to GlobalData UK Limited collecting my details provided via this form in accordance with the Privacy Policy
SUBSCRIBED

THANK YOU